Calabresi P - Search Results

1

Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection?

Calabresi P, Standaert DG. Calabresi P, et al. Neurobiol Dis. 2019 Dec;132:104579. doi: 10.1016/j.nbd.2019.104579. Epub 2019 Aug 22. Neurobiol Dis. 2019. PMID: 31445160 Free PMC article. Review.

2

Striatal synaptic plasticity: implications for motor learning and Parkinson's disease.

Pisani A, Centonze D, Bernardi G, Calabresi P. Pisani A, et al. Among authors: calabresi p. Mov Disord. 2005 Apr;20(4):395-402. doi: 10.1002/mds.20394. Mov Disord. 2005. PMID: 15719415 Review.

3

Pathological synaptic plasticity in the striatum: implications for Parkinson's disease.

Picconi B, Pisani A, Barone I, Bonsi P, Centonze D, Bernardi G, Calabresi P. Picconi B, et al. Among authors: calabresi p. Neurotoxicology. 2005 Oct;26(5):779-83. doi: 10.1016/j.neuro.2005.02.002. Epub 2005 May 31. Neurotoxicology. 2005. PMID: 15927256 Review.

4

Plastic and behavioral abnormalities in experimental Huntington's disease: a crucial role for cholinergic interneurons.

Picconi B, Passino E, Sgobio C, Bonsi P, Barone I, Ghiglieri V, Pisani A, Bernardi G, Ammassari-Teule M, Calabresi P. Picconi B, et al. Among authors: calabresi p. Neurobiol Dis. 2006 Apr;22(1):143-52. doi: 10.1016/j.nbd.2005.10.009. Epub 2005 Dec 2. Neurobiol Dis. 2006. PMID: 16326108

5

l-DOPA dosage is critically involved in dyskinesia via loss of synaptic depotentiation.

Picconi B, Paillé V, Ghiglieri V, Bagetta V, Barone I, Lindgren HS, Bernardi G, Angela Cenci M, Calabresi P. Picconi B, et al. Among authors: calabresi p. Neurobiol Dis. 2008 Feb;29(2):327-35. doi: 10.1016/j.nbd.2007.10.001. Epub 2007 Oct 11. Neurobiol Dis. 2008. PMID: 17997101

6

Molecular mechanisms underlying levodopa-induced dyskinesia.

Calabresi P, Di Filippo M, Ghiglieri V, Picconi B. Calabresi P, et al. Mov Disord. 2008;23 Suppl 3:S570-9. doi: 10.1002/mds.22019. Mov Disord. 2008. PMID: 18781674 Review.

7

The endocannabinoid system in Parkinson's disease.

Di Filippo M, Picconi B, Tozzi A, Ghiglieri V, Rossi A, Calabresi P. Di Filippo M, et al. Among authors: calabresi p. Curr Pharm Des. 2008;14(23):2337-47. doi: 10.2174/138161208785740072. Curr Pharm Des. 2008. PMID: 18781984 Review.

8

Hyperhomocysteinemia recurrence in levodopa-treated Parkinson's disease patients.

Belcastro V, Pierguidi L, Castrioto A, Menichetti C, Gorgone G, Ientile R, Pisani F, Rossi A, Calabresi P, Tambasco N. Belcastro V, et al. Among authors: calabresi p. Eur J Neurol. 2010 May;17(5):661-5. doi: 10.1111/j.1468-1331.2009.02894.x. Epub 2009 Dec 27. Eur J Neurol. 2010. PMID: 20050890

9

Synaptic dysfunction in Parkinson's disease.

Bagetta V, Ghiglieri V, Sgobio C, Calabresi P, Picconi B. Bagetta V, et al. Among authors: calabresi p. Biochem Soc Trans. 2010 Apr;38(2):493-7. doi: 10.1042/BST0380493. Biochem Soc Trans. 2010. PMID: 20298209 Review.

10

Levodopa-induced dyskinesias in patients with Parkinson's disease: filling the bench-to-bedside gap.

Calabresi P, Di Filippo M, Ghiglieri V, Tambasco N, Picconi B. Calabresi P, et al. Lancet Neurol. 2010 Nov;9(11):1106-17. doi: 10.1016/S1474-4422(10)70218-0. Epub 2010 Sep 27. Lancet Neurol. 2010. PMID: 20880751 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,380 results

Search Page

Filters